Omed IncOver The Counter Market:VICA
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Omed Inc | 120.0 | 0.0x | --- |
Forza Innovations Inc | 2.5K | 0.0x | --- |
Sunridge International | 4.9K | 0.0x | --- |
Medical International Technology Inc | 8.4K | 0.0x | --- |
Omnia Wellness Inc | 230.0 | 0.0x | --- |
Coded Growth Innovation Center Inc | 60.0 | --- | --- |
Company Information
Omed, Inc., formerly Optecmed, Inc., is focused on disruptive technologies in the fields of digital health, prosthetics, orthotics, diabetes, assistive devices, sports and wellbeing, and deep vein thrombosis (DVT). It has developed sensing technology under the brand name Flexisense, which uses a multitude of micro sensors to detect pressure as well as shear. It is also focusing on the fields of prosthetics and orthotics (P&O) and diabetic foot clinics in Europe. It holds a wholesale license for medicinal products for human use through C-Pharm, Ltd. It trades pharmaceutical products to wholesalers and manufacturers around the world. It also supplies medical consumables to cruise ships and merchant vessels. Its subsidiaries include C-Pharm, Ltd., HCi Viocare Technologies Limited and HCi Viocare Clinics UK Limited. Its HCi Viocare Technologies is developing hardware solutions focusing on providing on demand information in the fields of digital health, prosthetics, orthotics and DVT.
Contact Information
- Headquarters
- Kintyre House, 209 Govan RoadGLASGOW, United Kingdom G51 1HJ
- Phone
- 141-370-0321
- Fax
- 141-370-0322
Executives
- Chairman of the Board
- Constantinos Zertalis
- Chief Financial Officer, Secretary, Director
- Paraskevi Pylarinou
- Treasurer, Director
- Georgios Thrapsaniotis
- Director
- Yannis Levantis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $120.00 |
|---|---|
Revenue (TTM) | $335.2K |
Shares Outstanding | 122.0M |
Omed Inc does not pay a dividend. | |
Beta | 0.47 |
EPS | $-0.40 |
Book Value | $-0.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,241.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
